The European Bank for Reconstruction and Development (EBRD) will provide a EU€34.5mn (approx. US$37mn) loan to Dislog Group companies (owned by H&S Holding) in a bid to support Morocco’s pharmaceutical private sector
Part of the funding will be utilised to acquire Steripharma, a local pharmaceuticals manufacturer that provides affordable specialty generics medicines to replace expensive original products in the treatment of life-threatening diseases, while the remaining will finance the construction of a new green-certified industrial building and logistics platform as well as the installation of new solar panels.
The tranche will also be supported by a guarantee from the European Union through its European Fund for Sustainable Development (EFSD). Through it, Dislog will be able to expand into the pharmaceutical industry and capture higher-added value in Moroccan supply chains.
In addition to the loan, Dislog will also benefit from a technical assistance project funded by the EU to upgrade its human resources policies by implementing a gender diagnostic and action plan.
Finally, Dislog will further receive a grant from the FINTECC Programme which aims to help companies in participating EBRD economies to implement climate technologies.
